324
Last Update Posted: 2017-01-12
Recruiting has ended
All Genders accepted | 18 Years-55 Years |
200 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
The purpose of this study is to assess the efficacy of tryptophan vs. placebo, and voucher payments vs. a control condition, in the treatment of cocaine dependence.
This clinical trial uses a 2 by 2 design to compare tryptophan to placebo, and voucher incentives vs. a control condition, in the outpatient treatment of cocaine dependence- using a relapse prevention model of treatment intervention.
Eligibility
Relevant conditions:
Cocaine-Related Disorders
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov